Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations

OBJECTIVE: To investigate the clinical features of patients with non-small cell lung cancer (NSCLC) harboring uncommon epidermal growth factor receptor (EGFR) mutations, and the treatment outcomes of EGFR tyrosine kinase inhibitors (TKIs) in these patients. METHODS: We retrospectively analyzed the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Wang, Zheng, Hao, Xuezhi, Hu, Xingsheng, Wang, Hongyu, Wang, Yan, Ying, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348472/
https://www.ncbi.nlm.nih.gov/pubmed/28373750
http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348472/
https://www.ncbi.nlm.nih.gov/pubmed/28373750
http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.03

Ejemplares similares